These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3553053

  • 1. Review of the 4-quinolones.
    Eggleston M, Park SY.
    Infect Control; 1987 Mar; 8(3):119-25. PubMed ID: 3553053
    [Abstract] [Full Text] [Related]

  • 2. Clinical uses of nalidixic acid analogues: the fluoroquinolones.
    Høiby N.
    Eur J Clin Microbiol; 1986 Apr; 5(2):138-40. PubMed ID: 3013628
    [No Abstract] [Full Text] [Related]

  • 3. Symposium on antimicrobial agents. The quinolones.
    Walker RC, Wright AJ.
    Mayo Clin Proc; 1987 Nov; 62(11):1007-12. PubMed ID: 3312850
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.
    Kumada T, Neu HC.
    J Antimicrob Chemother; 1985 Nov; 16(5):563-74. PubMed ID: 3865923
    [Abstract] [Full Text] [Related]

  • 5. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R, Michéa-Hamzehpour M, Pechère JC.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
    Arpi M, Gahrn-Hansen B, Søgaard P, Bentzon MW.
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
    Chin NX, Novelli A, Neu HC.
    Antimicrob Agents Chemother; 1988 May; 32(5):656-62. PubMed ID: 3164987
    [Abstract] [Full Text] [Related]

  • 8. [Fluoroquinolones].
    Baykal M, Akalin E.
    Mikrobiyol Bul; 1987 Apr; 21(2):151-7. PubMed ID: 3482120
    [Abstract] [Full Text] [Related]

  • 9. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM, Baltch AL, Smith RP.
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [Abstract] [Full Text] [Related]

  • 10. In vitro evaluation of A-56619 and A-56620, two new quinolones.
    Barry AL, Thornsberry C, Jones RN.
    Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
    [Abstract] [Full Text] [Related]

  • 11. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
    Hooper DC, Wolfson JS.
    Antimicrob Agents Chemother; 1985 Nov; 28(5):716-21. PubMed ID: 2936302
    [No Abstract] [Full Text] [Related]

  • 12. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
    Neu HC.
    J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
    [Abstract] [Full Text] [Related]

  • 13. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 14. Place of quinolones in the therapeutic armoury.
    Van Klingeren B.
    Pharm Weekbl Sci; 1986 Feb 21; 8(1):40-1. PubMed ID: 3960692
    [Abstract] [Full Text] [Related]

  • 15. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT.
    Scand J Infect Dis Suppl; 1986 Feb 21; 49():115-23. PubMed ID: 3547618
    [Abstract] [Full Text] [Related]

  • 16. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD, Felmingham D, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Feb 21; 11(4):253-7. PubMed ID: 2941257
    [Abstract] [Full Text] [Related]

  • 17. [New oral quinolone compounds in chronic bronchitis].
    Davies BI, Maesen FP, Teengs JP, Baur C.
    Infection; 1986 Feb 21; 14 Suppl 1():S73-8. PubMed ID: 2937739
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG, Sörgel F, Gutzler F, Bartosik-Wich B.
    Infection; 1985 Feb 21; 13(5):219-24. PubMed ID: 2933340
    [Abstract] [Full Text] [Related]

  • 19. In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
    Berlin OG, Young LS, Bruckner DA.
    J Antimicrob Chemother; 1987 May 21; 19(5):611-5. PubMed ID: 3112095
    [Abstract] [Full Text] [Related]

  • 20. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
    King A, Shannon K, Phillips I.
    J Antimicrob Chemother; 1985 May 21; 15(5):551-8. PubMed ID: 3159712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.